Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05215132 · ClinicalTrials.gov registry record · Phase 4
Investigational MRI Clinical Software and Hardware
A Phase 4 study of Image, Body, sponsored by Northwestern University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 2,000
- Enrollment target
- 1
- Study location
NCT05215132 is a Phase 4 study of Image, Body that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 2,000 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05215132, a Phase 4 study of Image, Body, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients and healthy volunteers will be scanned in order to test new sequences.
Conditions Studied
Interventions
- RADIATION MRI
- DRUG Gadavist 2Ml Solution for Injection
Study Locations (1)
Illinois
- Northwestern University- Feinberg School of Medicine - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2019-12-19 |
| Est. Completion | 2026-01-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05215132
The ClinicalTrials.gov registry entry for NCT05215132 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Image, Body appearing as the primary indexed condition, and to 2 interventions - of which MRI is the first listed.
NCT05215132 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT05215132 about?
NCT05215132 is a clinical study titled "Investigational MRI Clinical Software and Hardware". Patients and healthy volunteers will be scanned in order to test new sequences.
What is the current status of trial NCT05215132?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 2,000 participants. The study started on 2019-12-19. Estimated completion is 2026-01-31.
What conditions does trial NCT05215132 study?
This clinical trial studies the following conditions: Image, Body.
What interventions are being tested in trial NCT05215132?
The interventions under investigation include: MRI (RADIATION), Gadavist 2Ml Solution for Injection (DRUG).
Who is sponsoring clinical trial NCT05215132?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05215132 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Image, Body
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.